Celiprolol Hydrochloride is a third-generation cardioselective beta-1 blocker with partial beta-2 agonist activity, used for hypertension and angina with a comparatively lower incidence of bronchospasm. Simson Pharma's Celiprolol Hydrochloride reference standard and impurities support compendial testing for this cardiovascular therapy.
Simson Pharma Global Ltd. (UK) and Simson Pharma Global LLC (USA) supply high-quality Celiprolol Hydrochloride Reference Standards, pharmacopoeial reference materials, and its related impurities to pharmaceutical manufacturers, CROs, analytical laboratories, universities, and regulatory organizations worldwide. To service the Europe and America market efficiently, Simson Pharma Limited has set up Simson Pharma Global Ltd. in United Kingdom and Simson Pharma Global LLC in USA respectively.
